Canada: 60 Day Bid, 120 Day Pill, 90 Day Decision... The Wisdom Of Solomon Or A Sign Of Things To Come...

Last Updated: December 2 2015
Article by Gordon G. Raman, Warren B. Learmonth and Kent Kufeldt

Most Read Contributor in Canada, September 2016

In Suncor's hostile bid for Canadian Oil Sands, the target adopted a poison pill that required a 120 day deposit period consistent with the required deposit period in the proposed new take-over bid regime. When Suncor asked the Alberta Securities Commission (ASC) to cease trade the pill, the ASC said it would leave the pill in place for now and cease trade the pill after a total of 90 days. Was this the right decision in the circumstances and is this a sign of further changes to the proposed new take-over bid regime?

In our previous bulletin we considered whether the harmonized take-over bid regime for non-exempt take-over bids proposed by The Canadian Securities Administrators (CSA) would mean the death of poison pills ( see here). The proposed regime is based on three principles:

  • 50% Minimum Tender Condition: this requires that a minimum of more than 50% of all outstanding target securities owned or held by persons other than the bidder and its joint actors be tendered and not withdrawn before the bidder can take up any securities under the bid (i.e. a majority of "independent" security holders must be in favour of the bid);
  • 10 Day Extension Requirement: if the minimum tender condition is met, and all other terms and conditions of the bid have been complied with or waived, the bid must be extended for an additional 10 days (effectively allowing other shareholders to tender once they know that a majority of security holders are in favour of the bid); and
  • 120 Day Deposit Period: the minimum period that a take-over bid must remain open is increased from 35 days to 120 days (subject to the ability of the target company to reduce this period to 35 days).

The proposed regime, and the longer deposit periods in particular, is intended to provide target boards more time to consider and respond to take-over bids.

In the midst of this proposed regime, on October 5, 2015 Suncor Energy Inc. (Suncor) launched a hostile bid for all of the issued and outstanding shares of Canadian Oil Sands Limited (COS). At the time of making the bid, COS had a poison pill in place that provided that the pill would not be triggered if a bid (a "permitted bid") effectively (i) had a 50% Minimum Tender Condition; (ii) included a 10 Day Extension Requirement; and (iii) had a deposit period of 60 days. Suncor structured its bid as a "permitted bid". On October 6, 2015, the Board of COS adopted a new poison pill which provided that in order for a bid to be a "permitted bid" the minimum deposit period must be 120 days.

Under the existing take-over bid regime, the position of the CSA has generally been that there will come a time when a poison pill must go and shareholders must be able to decide to tender or not tender to a bid. After an appropriate length of time, a bidder typically applies to the securities regulators to have the poison pill "cease traded" (effectively rendered ineffective). The appropriate length of time depends on the facts, including whether the Board of the target has had sufficient time to evaluate the bid and potentially surface other bids and the likelihood of other bidders emerging, but the period is generally in the range of 45 to 60 days.

Suncor applied to the ASC to cease trade the new COS poison pill. In its submissions, Suncor argued that (i) under the original COS poison pill the directors had determined that 60 days was sufficient time to evaluate a bid, (ii) from the time that Suncor first approached COS (in March) until the expiry of the bid, almost 10 months would have elapsed; (iii) there are only a limited number of potential bidders who would be interested in COS and if none of them had emerged within the 60 days, they were not likely to emerge; (iv) adopting a new poison pill that changed the rules was an improper defensive tactic; and (v) COS did not have the new poison pill approved by shareholders. Suncor also specifically made the argument that although the proposed take-over bid regime contemplates a 120 deposit period, until the regime is in force the securities commission should not apply those provisions in determining whether to cease trade the new poison pill. At the hearing an executive of Suncor went so far as to state that it would not extend its bid if the ASC affirmed the new poison pill.

In response, COS argued that the original poison pill was adopted at "a very different time, in a very different context, and in very different market conditions" and that it should not preclude COS from adopting a new pill in the face of a hostile bid. COS went on to argue that in the current circumstances the Board and its advisors were of the view that 120 days was required in order to ensure that shareholders were able to make an informed choice. COS argued this additional time was required because (i) additional information with respect to Syncrude's 2016 budget would be available in early December and the lack of this information created an informational advantage to Suncor, (ii) if it took Suncor almost 8 months to determine to make a bid, it is not unreasonable that other potential bidders may also need more than 60 days in order to formulate a potential bid, (iii) 25 parties were reviewing the opportunity to acquire COS and 4 parties had signed confidentiality agreements, (iv) the bid was timed to take advantage of the political and regulatory uncertainty in the Alberta energy industry; and (v) the 120 period under the new poison pill was consistent with the minimum deposit period under the proposed new take-over bid regime.

In its oral decision, the ASC acknowledged that the implementation of the new pill was in the best interests of shareholders and additional time would be useful, and possibly necessary, because potential bidders and COS shareholders would likely want to see the information related to Syncrude's 2016 budget. The ASC also considered Suncor's stated intention not to extend its bid if the 120 day period in the new poison pill was upheld. Ultimately, the ASC concluded that an additional 30 days would be in the best interests of shareholders and determined to cease trade the pill on January 4, 2016. In coming to its decision the ASC did comment that the 60 day period in the original pill may have been sufficient based on the market standards at the time the original pill was adopted, but that did not mean that a 60 day period was sufficient for any bid. Finally, the ASC touched on the proposed new take-over bid regime's requirement for a 120 day bid period and observed that if it comes into force, all bids like Suncor's would be required to have a 120 day bid period.

In the end, the ASC has brought certainty to the length of time that COS' new poison pill will be allowed to stand. The decision, however, does leave two questions. Will the splitting the difference in bid periods be seen as the wisdom of Solomon or the impetus for Suncor to drop its bid, and is settling on a 90 day period for the COS poison pill a signal of any changes to the new take-over bid proposals?

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.